nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Respiratory distress—Sorafenib—liver cancer	0.0172	0.0781	CcSEcCtD
Terlipressin—Skin necrosis—Epirubicin—liver cancer	0.0115	0.0525	CcSEcCtD
Terlipressin—Skin necrosis—Doxorubicin—liver cancer	0.0107	0.0485	CcSEcCtD
Terlipressin—Skin exfoliation—Sorafenib—liver cancer	0.0104	0.0473	CcSEcCtD
Terlipressin—Cardiac failure—Sorafenib—liver cancer	0.00811	0.0369	CcSEcCtD
Terlipressin—Hyponatraemia—Sorafenib—liver cancer	0.00795	0.0361	CcSEcCtD
Terlipressin—Acute coronary syndrome—Sorafenib—liver cancer	0.00602	0.0273	CcSEcCtD
Terlipressin—Myocardial infarction—Sorafenib—liver cancer	0.00598	0.0272	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—F2—liver cancer	0.00563	0.00721	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00552	0.00708	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CHN2—liver cancer	0.00547	0.00702	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00527	0.00676	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.0051	0.00653	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCE—liver cancer	0.00509	0.00652	CbGpPWpGaD
Terlipressin—Cardiac disorder—Sorafenib—liver cancer	0.00508	0.0231	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00505	0.00648	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00505	0.00648	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IFT88—liver cancer	0.00501	0.00642	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CCR4—liver cancer	0.00498	0.00639	CbGpPWpGaD
Terlipressin—Angiopathy—Sorafenib—liver cancer	0.00497	0.0226	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CCR4—liver cancer	0.00495	0.00634	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00478	0.00613	CbGpPWpGaD
Terlipressin—Malnutrition—Sorafenib—liver cancer	0.00477	0.0217	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—liver cancer	0.00446	0.0203	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—TRIO—liver cancer	0.00424	0.00543	CbGpPWpGaD
Terlipressin—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00413	0.0188	CcSEcCtD
Terlipressin—Hypertension—Sorafenib—liver cancer	0.00412	0.0187	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR4—liver cancer	0.00406	0.00521	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00403	0.0183	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—F2—liver cancer	0.00395	0.00506	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—F2—liver cancer	0.0039	0.005	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—F2—liver cancer	0.00387	0.00496	CbGpPWpGaD
Terlipressin—Skin exfoliation—Epirubicin—liver cancer	0.00385	0.0175	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—TRIO—liver cancer	0.00385	0.00493	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00383	0.00491	CbGpPWpGaD
Terlipressin—Nervous system disorder—Sorafenib—liver cancer	0.00382	0.0174	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CHN2—liver cancer	0.00379	0.00486	CbGpPWpGaD
Terlipressin—Skin disorder—Sorafenib—liver cancer	0.00378	0.0172	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00377	0.00484	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CHN2—liver cancer	0.00377	0.00483	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR4—liver cancer	0.00369	0.00473	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Epirubicin—liver cancer	0.00359	0.0163	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—liver cancer	0.00356	0.0162	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—liver cancer	0.00353	0.00453	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IFT88—liver cancer	0.00347	0.00445	CbGpPWpGaD
Terlipressin—Dyspnoea—Sorafenib—liver cancer	0.00347	0.0158	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—IFT88—liver cancer	0.00345	0.00442	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00336	0.0153	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—liver cancer	0.00332	0.0151	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—liver cancer	0.00313	0.0142	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—liver cancer	0.0031	0.0141	CcSEcCtD
Terlipressin—Abdominal pain—Sorafenib—liver cancer	0.00308	0.014	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—SHC3—liver cancer	0.00307	0.00393	CbGpPWpGaD
Terlipressin—Cardiac failure—Epirubicin—liver cancer	0.003	0.0136	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—liver cancer	0.00294	0.0134	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—TRIO—liver cancer	0.00294	0.00377	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—TRIO—liver cancer	0.00292	0.00374	CbGpPWpGaD
Terlipressin—Hot flush—Doxorubicin—liver cancer	0.00289	0.0132	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—F2—liver cancer	0.00287	0.00368	CbGpPWpGaD
Terlipressin—Menopausal symptoms—Doxorubicin—liver cancer	0.00287	0.013	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR4—liver cancer	0.00282	0.00361	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR4—liver cancer	0.0028	0.00358	CbGpPWpGaD
Terlipressin—Cardiac failure—Doxorubicin—liver cancer	0.00277	0.0126	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—liver cancer	0.00272	0.0124	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—TRIO—liver cancer	0.00267	0.00342	CbGpPWpGaD
Terlipressin—Diarrhoea—Sorafenib—liver cancer	0.00266	0.0121	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—liver cancer	0.00265	0.0034	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—TRIO—liver cancer	0.00265	0.00339	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00262	0.00335	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.0026	0.00333	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR4—liver cancer	0.00256	0.00328	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—PIK3CA—liver cancer	0.00255	0.00327	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR4—liver cancer	0.00254	0.00325	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00248	0.00318	CbGpPWpGaD
Terlipressin—Vomiting—Sorafenib—liver cancer	0.00247	0.0112	CcSEcCtD
Terlipressin—Headache—Sorafenib—liver cancer	0.00244	0.0111	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—CYCS—liver cancer	0.00244	0.00312	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FST—liver cancer	0.00238	0.00305	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PRKCE—liver cancer	0.00234	0.003	CbGpPWpGaD
Terlipressin—Nausea—Sorafenib—liver cancer	0.00231	0.0105	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00228	0.00292	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TRIO—liver cancer	0.00227	0.00291	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR4—liver cancer	0.00218	0.00279	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SHC3—liver cancer	0.00213	0.00273	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PRKCE—liver cancer	0.00212	0.00272	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00212	0.00271	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SHC3—liver cancer	0.00211	0.00271	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00211	0.0027	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CSF2—liver cancer	0.00207	0.00265	CbGpPWpGaD
Terlipressin—Bradycardia—Epirubicin—liver cancer	0.00206	0.00937	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.00202	0.00259	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—F2—liver cancer	0.00199	0.00255	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—F2—liver cancer	0.00198	0.00254	CbGpPWpGaD
Terlipressin—Bradycardia—Doxorubicin—liver cancer	0.00191	0.00867	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CSF2—liver cancer	0.00188	0.00241	CbGpPWpGaD
Terlipressin—Cardiac disorder—Epirubicin—liver cancer	0.00188	0.00854	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—liver cancer	0.00184	0.00835	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—PIK3CA—liver cancer	0.00177	0.00226	CbGpPWpGaD
Terlipressin—Malnutrition—Epirubicin—liver cancer	0.00176	0.00801	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—liver cancer	0.00174	0.0079	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—ADAM17—liver cancer	0.00172	0.00221	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—liver cancer	0.00172	0.0022	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00171	0.00219	CbGpPWpGaD
Terlipressin—Angiopathy—Doxorubicin—liver cancer	0.0017	0.00773	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—FST—liver cancer	0.00165	0.00212	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FST—liver cancer	0.00164	0.0021	CbGpPWpGaD
Terlipressin—Malnutrition—Doxorubicin—liver cancer	0.00163	0.00741	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—F2—liver cancer	0.00162	0.00208	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PRKCE—liver cancer	0.00162	0.00208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PSMD10—liver cancer	0.00162	0.00208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PSMA4—liver cancer	0.00162	0.00208	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PRKCE—liver cancer	0.00161	0.00206	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—liver cancer	0.00158	0.00202	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TRIO—liver cancer	0.00158	0.00202	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TRIO—liver cancer	0.00156	0.00201	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CG—liver cancer	0.00155	0.00199	CbGpPWpGaD
Terlipressin—Hypertension—Epirubicin—liver cancer	0.00152	0.00692	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—CCR4—liver cancer	0.00151	0.00194	CbGpPWpGaD
Terlipressin—Chest pain—Epirubicin—liver cancer	0.0015	0.00682	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CCR4—liver cancer	0.0015	0.00192	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00149	0.00677	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—F2—liver cancer	0.00147	0.00189	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PRKCE—liver cancer	0.00147	0.00189	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PRKCE—liver cancer	0.00146	0.00187	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—liver cancer	0.00146	0.00187	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CSF2—liver cancer	0.00143	0.00184	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CSF2—liver cancer	0.00142	0.00183	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CG—liver cancer	0.00141	0.00181	CbGpPWpGaD
Terlipressin—Nervous system disorder—Epirubicin—liver cancer	0.00141	0.00641	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—liver cancer	0.00141	0.0064	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—liver cancer	0.0014	0.00638	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—liver cancer	0.0014	0.00179	CbGpPWpGaD
Terlipressin—Skin disorder—Epirubicin—liver cancer	0.0014	0.00635	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—liver cancer	0.00139	0.00631	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00138	0.00627	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CD—liver cancer	0.00137	0.00175	CbGpPWpGaD
Terlipressin—Nervous system disorder—Doxorubicin—liver cancer	0.00131	0.00593	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CSF2—liver cancer	0.0013	0.00167	CbGpPWpGaD
Terlipressin—Tachycardia—Doxorubicin—liver cancer	0.0013	0.0059	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CSF2—liver cancer	0.00129	0.00166	CbGpPWpGaD
Terlipressin—Skin disorder—Doxorubicin—liver cancer	0.00129	0.00588	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—liver cancer	0.00128	0.00583	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—liver cancer	0.00127	0.00163	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PRKCE—liver cancer	0.00125	0.00161	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00124	0.00565	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CD—liver cancer	0.00124	0.00159	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ADAM17—liver cancer	0.00119	0.00153	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CB—liver cancer	0.00119	0.00153	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF2—liver cancer	0.00119	0.00152	CbGpPWpGaD
Terlipressin—Dyspnoea—Doxorubicin—liver cancer	0.00119	0.00539	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—ADAM17—liver cancer	0.00119	0.00152	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—RAF1—liver cancer	0.00115	0.00147	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00115	0.00522	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—liver cancer	0.00114	0.00517	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—F2—liver cancer	0.00113	0.00144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMD10—liver cancer	0.00112	0.00144	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMA4—liver cancer	0.00112	0.00144	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—F2—liver cancer	0.00112	0.00143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMD10—liver cancer	0.00111	0.00143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMA4—liver cancer	0.00111	0.00143	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CSF2—liver cancer	0.00111	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—RAF1—liver cancer	0.00111	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—H2AFX—liver cancer	0.00109	0.0014	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—liver cancer	0.00109	0.0014	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—liver cancer	0.00108	0.00139	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—liver cancer	0.00108	0.00138	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—liver cancer	0.00107	0.00137	CbGpPWpGaD
Terlipressin—Abdominal pain—Doxorubicin—liver cancer	0.00105	0.00478	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—F2—liver cancer	0.00102	0.00131	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—F2—liver cancer	0.00101	0.0013	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—liver cancer	0.000993	0.00127	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—liver cancer	0.000989	0.00127	CbGpPWpGaD
Terlipressin—Diarrhoea—Epirubicin—liver cancer	0.000984	0.00447	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—liver cancer	0.000978	0.00125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—liver cancer	0.000971	0.00125	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—liver cancer	0.000947	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—liver cancer	0.00094	0.00121	CbGpPWpGaD
Terlipressin—Vomiting—Epirubicin—liver cancer	0.000915	0.00416	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—liver cancer	0.000911	0.00414	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—KDR—liver cancer	0.000905	0.00116	CbGpPWpGaD
Terlipressin—Headache—Epirubicin—liver cancer	0.000901	0.0041	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—MAPK14—liver cancer	0.000899	0.00115	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ESR1—liver cancer	0.000882	0.00113	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—F2—liver cancer	0.000871	0.00112	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCE—liver cancer	0.00087	0.00112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCE—liver cancer	0.000864	0.00111	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—liver cancer	0.00086	0.0011	CbGpPWpGaD
Terlipressin—Nausea—Epirubicin—liver cancer	0.000854	0.00388	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—liver cancer	0.000854	0.00109	CbGpPWpGaD
Terlipressin—Vomiting—Doxorubicin—liver cancer	0.000846	0.00385	CcSEcCtD
Terlipressin—Headache—Doxorubicin—liver cancer	0.000834	0.00379	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—APC—liver cancer	0.000834	0.00107	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—liver cancer	0.000834	0.00107	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—liver cancer	0.000825	0.00106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF2—liver cancer	0.000824	0.00106	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—liver cancer	0.000819	0.00105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF2—liver cancer	0.000818	0.00105	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—liver cancer	0.000791	0.00359	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—liver cancer	0.000784	0.001	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CSF2—liver cancer	0.000769	0.000987	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RAF1—liver cancer	0.000768	0.000984	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CSF2—liver cancer	0.000764	0.000979	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—RAF1—liver cancer	0.000762	0.000977	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—H2AFX—liver cancer	0.000758	0.000972	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—liver cancer	0.000758	0.000972	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—H2AFX—liver cancer	0.000753	0.000965	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—liver cancer	0.000753	0.000965	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—liver cancer	0.00075	0.000961	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—liver cancer	0.000744	0.000954	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—liver cancer	0.000733	0.00094	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—liver cancer	0.000726	0.000931	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SERPINE1—liver cancer	0.000725	0.000929	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—liver cancer	0.000718	0.00092	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—liver cancer	0.000688	0.000882	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—liver cancer	0.000686	0.000879	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—liver cancer	0.000683	0.000876	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—liver cancer	0.000681	0.000873	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—liver cancer	0.000659	0.000845	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAF1—liver cancer	0.000654	0.000839	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—liver cancer	0.000639	0.000819	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—liver cancer	0.000639	0.000819	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—liver cancer	0.000627	0.000804	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK14—liver cancer	0.000623	0.000799	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—liver cancer	0.000623	0.000798	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK14—liver cancer	0.000619	0.000793	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ESR1—liver cancer	0.000611	0.000784	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—liver cancer	0.00061	0.000782	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ESR1—liver cancer	0.000607	0.000778	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—F2—liver cancer	0.000604	0.000774	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—F2—liver cancer	0.000599	0.000769	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—liver cancer	0.000599	0.000769	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—liver cancer	0.000593	0.00076	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—liver cancer	0.000588	0.000753	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—liver cancer	0.000587	0.000752	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—liver cancer	0.000584	0.000748	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—liver cancer	0.000578	0.000741	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—liver cancer	0.000578	0.000741	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—liver cancer	0.000574	0.000735	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—liver cancer	0.000574	0.000735	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—liver cancer	0.000572	0.000733	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUN—liver cancer	0.000571	0.000732	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—liver cancer	0.000566	0.000726	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—liver cancer	0.000555	0.000712	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—liver cancer	0.000553	0.000709	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—liver cancer	0.000543	0.000696	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK8—liver cancer	0.00054	0.000692	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—liver cancer	0.000539	0.000691	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—liver cancer	0.000539	0.00069	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—liver cancer	0.000508	0.000651	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—liver cancer	0.000504	0.000647	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—liver cancer	0.000503	0.000645	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SERPINE1—liver cancer	0.000502	0.000644	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—liver cancer	0.0005	0.00064	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SERPINE1—liver cancer	0.000499	0.00064	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—liver cancer	0.000499	0.000639	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—liver cancer	0.000497	0.000638	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—liver cancer	0.000494	0.000633	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—liver cancer	0.000494	0.000633	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—liver cancer	0.000459	0.000588	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TGFB1—liver cancer	0.000458	0.000587	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—liver cancer	0.000457	0.000586	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—liver cancer	0.000454	0.000582	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAF1—liver cancer	0.000454	0.000581	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAF1—liver cancer	0.00045	0.000577	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—liver cancer	0.000443	0.000568	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—liver cancer	0.000443	0.000568	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—liver cancer	0.00044	0.000564	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—liver cancer	0.00044	0.000564	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—liver cancer	0.000424	0.000543	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—liver cancer	0.000423	0.000542	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—liver cancer	0.00042	0.000538	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—liver cancer	0.000416	0.000533	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—liver cancer	0.000413	0.000529	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—liver cancer	0.000411	0.000527	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—liver cancer	0.000408	0.000523	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—liver cancer	0.000407	0.000522	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—liver cancer	0.000407	0.000521	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—liver cancer	0.000405	0.000519	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—liver cancer	0.000404	0.000518	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—liver cancer	0.000404	0.000518	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—liver cancer	0.000402	0.000515	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—liver cancer	0.000396	0.000508	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUN—liver cancer	0.000396	0.000507	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—liver cancer	0.000394	0.000505	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUN—liver cancer	0.000393	0.000503	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—liver cancer	0.000393	0.000503	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—liver cancer	0.00039	0.0005	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—liver cancer	0.000389	0.000499	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—liver cancer	0.000385	0.000493	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—liver cancer	0.000383	0.000492	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—liver cancer	0.000382	0.00049	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—liver cancer	0.000381	0.000488	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—liver cancer	0.000377	0.000483	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK8—liver cancer	0.000374	0.00048	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—liver cancer	0.000373	0.000479	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK8—liver cancer	0.000372	0.000476	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—liver cancer	0.000371	0.000475	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—liver cancer	0.00036	0.000462	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—liver cancer	0.000346	0.000443	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—liver cancer	0.000345	0.000442	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—liver cancer	0.000343	0.00044	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—liver cancer	0.000342	0.000439	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—liver cancer	0.00034	0.000436	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—liver cancer	0.000318	0.000408	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—liver cancer	0.000318	0.000408	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TGFB1—liver cancer	0.000317	0.000407	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—liver cancer	0.000316	0.000405	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TGFB1—liver cancer	0.000315	0.000404	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—liver cancer	0.000294	0.000377	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—liver cancer	0.000292	0.000374	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—liver cancer	0.00027	0.000346	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—liver cancer	0.000268	0.000344	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—liver cancer	0.000261	0.000335	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—liver cancer	0.000259	0.000332	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—liver cancer	0.00025	0.00032	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—liver cancer	0.000248	0.000318	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—liver cancer	0.000239	0.000306	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—liver cancer	0.000237	0.000304	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—liver cancer	0.000221	0.000283	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—liver cancer	0.000219	0.000281	CbGpPWpGaD
